Joseph A MD Sorge insider trades: Stratagene (STGN) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Joseph reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 1, 2007 | STGN | ↓ Sell10b5-1 | 73,000 | $10.75 | $785K | Direct | May 2, 2007 (1d) |
| Apr 16, 2007 | STGN | ↓ Sell10b5-1 | 613,456 | $10.71 | $6.6M | Direct | Apr 16, 2007 (0d) |
| Apr 9, 2007 | STGN | ↓ Sell10b5-1 | 165,444 | $10.71 | $1.8M | Direct | Apr 11, 2007 (2d) |
| Mar 16, 2007 | STGN | ↓ Sell | 22,450 | $8.34 | $187K | Direct | Apr 11, 2007 (26d) |
| Mar 15, 2007 | STGN | ↓ Sell | 4,200 | $8.40 | $35K | Direct | Mar 19, 2007 (4d) |
| Mar 9, 2007 | STGN | ↓ Sell | 8,350 | $8.65 | $72K | Direct | Mar 13, 2007 (4d) |
| Mar 2, 2007 | STGN | ↓ Sell10b5-1 | 2,500 | $9.10 | $23K | Direct | Mar 5, 2007 (3d) |
| Mar 1, 2007 | STGN | ↓ Sell | 21,600 | $9.24 | $200K | Direct | Mar 1, 2007 (0d) |
| Dec 15, 2006 | STGN | ↓ Sell | 88,000 | $7.45 | $656K | Direct | Dec 19, 2006 (4d) |
| Aug 16, 2005 | STGN | ↓ Sell | 105,000 | $9.25 | $971K | By BioSense Partners, LP | Aug 17, 2005 (1d) |
| Aug 16, 2005 | STGN | ↓ Sell | 35,000 | $9.25 | $324K | By J.A. Sorge Trust I | Aug 17, 2005 (1d) |
| Aug 16, 2005 | STGN | ↓ Sell | 35,000 | $9.25 | $324K | By J.A. Sorge Trust III | Aug 17, 2005 (1d) |
| Jun 13, 2005 | STGN | ↓ Sell | 60,000 | $8.50 | $510K | By BioSense Partners, LP | Jun 14, 2005 (1d) |
| Jun 13, 2005 | STGN | ↓ Sell | 20,000 | $8.50 | $170K | By J.A. Sorge Trust III | Jun 14, 2005 (1d) |
| Jun 13, 2005 | STGN | ↓ Sell | 20,000 | $8.50 | $170K | By J.A. Sorge Trust I | Jun 14, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Joseph A MD Sorge's insider trades
Joseph A MD Sorge is President, CEO Chairman of Bd at Stratagene (STGN). Since Jun 13, 2005, Joseph has reported no open-market purchases and 15 sales worth $12.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
4 sales (72% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every STGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.